Systemic exposure following intravitreal administration of therapeuticagents: an integrated pharmacokinetic approach. 1. THR-149

Oxurion NV

Gaston Geenslaan 1
B-3001 Leuven
Belgium

©2022 Oxurion NV. All rights reserved.
Linkedin-in Twitter